Best Online Medical Weight-Loss Programs
Released: Last reviewed:
How we rank online medical weight-loss programs: the seven v4.1 categories, the scores from pages read November 20, 2026, and where NexLife fits.
Our ranking categories
| Category | Points |
|---|---|
| Pricing transparency | 20 |
| Total annual cost | 20 |
| Clinical oversight | 15 |
| Pharmacy transparency | 15 |
| Support | 10 |
| Regulatory disclosure | 10 |
| Accessibility | 10 |
The item-level scoring guide says exactly how each point is earned. A program whose pages we cannot read is shown as not scored.
Programs ranked by score (pages read November 20, 2026)
- NexLife: 86/100
- Eden Health: 78/100
- Found: 75/100
- Sequence (WW Clinic): 72/100
- Mochi Health: 68/100
- Form Health: 67/100
- LifeMD: 64/100
- Calibrate: 64/100
- Noom Med: 56/100
- Henry Meds: 53/100
Ro Body and Hims & Hers are not scored: their sites returned HTTP 403 to our reads.
Where NexLife fits
NexLife has the highest computed score. It publishes the same price at every dose for compounded semaglutide ($95–$109 a month) and tirzepatide ($115–$129), names its medical group and medical director, and lists 503A pharmacies. It lost points for an open FDA warning letter (730096) and for conflicting price, state, pharmacy and billing statements on its own pages. Eden Health and Mondae list lower month-to-month semaglutide prices. See the NexLife review and the provider directory.
Methodology note
The order is the computed result of the scoring guide; programs cannot pay to move up, and commissions never change a score. We do not use star ratings or review counts.
Frequently asked questions
What is the best online medical weight-loss program?
On our scores from November 20, 2026, NexLife ranks first and Eden Health second, but the right program depends on whether you want a compounded or brand drug, insurance or cash pay, and how much clinician contact you need. Compare each program’s 12-month cost and terms on its review page.
Do you use star ratings?
No. Scores come from a published seven-category scoring guide applied to each program’s own pages on a stated date; we use no star ratings or review counts, and programs cannot pay to rank higher.
Sources
- American Telehealth Review v4.1 scoring guide, published November 20, 2026.
- FDA: Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, content current as of October 1, 2026; read November 20, 2026.
- FDA warning letters index, searched November 20, 2026.